Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a revision label updated to v3.6.3, replacing the previous v3.6.0 to indicate a newer build deployment.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status is updated to not recruiting, reflecting that participants are no longer being sought. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a header formatting change for Intervention/Treatment were added, along with a version update to v3.6.0.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, signaling a new release of the page content for the LIBRETTO-001 study listing.SummaryDifference0.0%

- Check55 days agoChange DetectedThe website revision tag was updated from v3.5.3 to v3.5.4, indicating a small deployment update to the page’s framework. It does not imply changes to the study information shown on the page.SummaryDifference0.0%

- Check69 days agoChange DetectedA new publication citation was added to the Publications section, detailing a 2024 Oncologist article on selpercatinib's long-term safety and related RET-activated tumors.SummaryDifference0.0%

- Check77 days agoChange DetectedClinicalTrials.gov’s study details page now reflects a newer software/content release revision (v3.5.3 instead of v3.5.2), without changing any study-specific information.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.